Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03667404
PHASE2

Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study

Sponsor: Northwestern University

View on ClinicalTrials.gov

Summary

This study will evaluate the safety and tolerability of a dietary fiber, resistant maltodextrin, in people with Parkinson's disease. It will also evaluate the fiber's effect on the gut microbiome and potential effects on motor function and non-motor functions. Half of the participants will receive resistant maltodextrin and the other half will receive a control substance, maltodextrin.

Official title: Gut Microbial Remodeling With Resistant Maltodextrin for Motor and Non-motor Symptoms in Parkinson's Disease: Safety and Tolerability Study

Key Details

Gender

All

Age Range

60 Years - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2018-11-06

Completion Date

2026-10-31

Last Updated

2026-04-15

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Resistant maltodextrin

Resistant maltodextrin powder

DIETARY_SUPPLEMENT

maltodextrin

maltodextrin powder

Locations (1)

Northwestern University

Chicago, Illinois, United States